The potential of ciliary neurotrophic factor receptor as a biomarker for urine-based noninvasive diagnosis of prostate cancer
CNTFR is a promising noninvasive diagnostic biomarker for prostate cancer. Its reduced expression in urine and tissues, along with its association with poor prognosis, highlights its potential for improving prostate cancer diagnosis and outcomes through noninvasive methods.
Authors
- Jiyeon Yoo (ORCID: https://orcid.org/0000-0002-9794-853X)
- Hyun Sik Kim (ORCID: https://orcid.org/0000-0002-4672-7710)
- Sungryul Yu
Institutions
- Yonsei University (KR)
- Semyung University (KR)
Publication Details
- Journal
- Laboratory Medicine
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1093/labmed/lmaf025
- Primary Topic
- Cardiovascular Disease and Adiposity
- Type
- article
- Field-Weighted Citation Impact
- 0.00